참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Toluene | HCID 1140 | — |
| 반응물 | 2-Chloro-5-methyl-pyridine | HCID 581393 | — |
| 반응물 | 2-(Dicyclohexylphosphino)-2'-methylbiphenyl | HCID 2734938 | — |
| 반응물 | Sodium t-butoxide | HCID 23676156 | — |
| 반응물 | 1-(4-(3-(4-Aminophenoxy)pyrazin-2-yl)piperidin-1-yl)ethanone | HCID 59374162 | — |
| 촉매 | Bis(dibenzylideneacetone)palladium | HCID 9811564 | — |
| 용매 | Dichloromethane | HCID 6344 | — |
| 생성물 | 1-(4-(3-(4-(5-Methylpyridin-2-ylamino)phenoxy)pyrazin-2-yl)piperidin-1-yl)ethanone | HCID 46220517 | — |
반응 단계
Into a sealed tube were added 2-chloro-5-methylpyridine (0.055 g, 0.431 mmol), 1-(4-(3-(4-aminophenoxy)pyrazin-2-yl)piperidin-1-yl)ethanone (0.148 g, 0.474 mmol), tris(dibenzylideneacetone)dipalladium(0) (0.024 g, 0.026 mmol), 2-(dicyclohexylphosphino)-2′-methylbiphenyl (0.016 g, 0.043 mmol), sodium tert-butoxide (0.124 g, 1.293 mmol), and toluene (2.16 mL, 0.431 mmol). After the mixture was degassed for 5 min, the reaction was stirred at 100° C. for 18 h. The cooled reaction was diluted with CH2Cl2 and washed with water. The organic layer was dried (MgSO4), filtered, and concentrated in vacuo. ISCO purification (20% to 80% EtOAc (10% MeOH)/Hexanes), followed by reverse phase HPLC (Shimadzu) afforded 1-(4-(3-(4-(5-methylpyridin-2-ylamino)phenoxy)pyrazin-2-yl)piperidin-1-yl)ethanone as a white amorphous solid. MS (ESI, pos. ion) m/z: 404.0 (M+1). IC50 (uM) 0.00004.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US08637500B2 |
|---|
| 출처 데이터셋 | uspto-grants-2014_01 |
|---|
| ORD ID | ord-55520cf068464924b82101a379953731 |
|---|
| 출처 메모 | uspto-grants-2014_01 |
|---|